Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
GLYCOPHOS (Fresenius Kabi Australia Pty Ltd)
Product name
GLYCOPHOS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
199 working days (255)
Active ingredients
sodium glycerophosphate hydrate
Registration type
NCE/NBE
Indication
GLYCOPHOS (concentrated solution for injection) is indicated in adult and paediatric patients as a supplement to parenteral nutrition to meet the daily requirements of phosphate.